Annual Report

Overview

The report highlights Proteomics International's transition from research and development to commercialisation, including PromarkerD launches in Australia and the United States. It also reports a $12 million capital raise to support commercial rollouts and scaling of global operations. The ESG section states that the Group is not currently subject to greenhouse-gas and energy reporting obligations.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2025
Period: Ends 30 June 2025
Publication date: 27 August 2025
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services